MGRX DEF 14A: Board change

Mangoceuticals

Filed with the SEC on · accession 0001493152-26-052901

MGRX filed a DEF 14A (proxy statement) with the SEC on Nov 17, 2026. Mangoceuticals filed a definitive proxy statement for its combined 2025/2026 annual meeting, asking stockholders to elect four incumbent directors, approve a reverse stock split with a ratio between 1-for-2 and 1-for-25, approve an amendment to the 2022 Equity Incentive Plan, and ratify the… The stock moved -0.2% by the first close after the filing.

Summary of the filing

Mangoceuticals filed a definitive proxy statement for its combined 2025/2026 annual meeting, asking stockholders to elect four incumbent directors, approve a reverse stock split with a ratio between 1-for-2 and 1-for-25, approve an amendment to the 2022 Equity Incentive Plan, and ratify the appointment of Turner, Stone & Company as independent auditors.

Key details

RegistrantMangoceuticals, Inc.
Independent registered public accounting firm proposed for ratificationTurner, Stone & Company, L.L.P.
Chairman and director nomineeJacob D. Cohen
Director nomineeLorraine D'Alessio
Director nomineeAlex P. Hamilton
Director nomineeDr. Kenny Myers

How MGRX stock reacted

Close before

$0.16

Nov 16, 2026

First close after

-0.19%

$0.16

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for MGRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MGRX?

Click here

Frequently asked questions

What did MGRX file with the SEC on Nov 17, 2026?

MGRX filed a DEF 14A (Board change). Mangoceuticals filed a definitive proxy statement for its combined 2025/2026 annual meeting, asking stockholders to elect four incumbent directors, approve a reverse stock split with a ratio between 1-for-2 and 1-for-25, approve an amendment to the 2022 Equity Incentive Plan, and ratify the appointment of Turner, Stone & Company as independent auditors.

What does a board change mean for MGRX stock?

Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.

How do I read a DEF 14A?

Information for the shareholder meeting: votes, board members and executive pay. Executive pay tables show how management is paid. Check the items shareholders vote on (mergers, new share plans).

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A DEF 14A (proxy statement): Information for the shareholder meeting: votes, board members and executive pay.

How did MGRX stock react to this filing?

MGRX closed at $0.16 before the filing and $0.16 on Nov 17, 2026 (-0.19%).

Other MGRX SEC filings

Get alerts when MGRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days